73 companies

Palantir Technologies

Market Cap: US$414.7b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$174.01

7D

-2.2%

1Y

164.6%

Workday

Market Cap: US$61.6b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$230.82

7D

2.5%

1Y

-11.0%

Duos Technologies Group

Market Cap: US$178.2m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

New

DUOT

US$8.80

7D

-11.3%

1Y

134.0%

Gorilla Technology Group

Market Cap: US$371.0m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$12.94

7D

-8.7%

1Y

214.1%

Procore Technologies

Market Cap: US$11.7b

Provides a cloud-based construction management platform and related products and services in the United States and internationally.

PCOR

US$75.49

7D

-5.2%

1Y

9.2%

RenovoRx

Market Cap: US$27.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$0.75

7D

-22.0%

1Y

-31.2%

Circle Internet Group

Market Cap: US$19.3b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$81.89

7D

-20.6%

1Y

n/a

OS Therapies

Market Cap: US$60.4m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.80

7D

-2.2%

1Y

-18.2%

Zscaler

Market Cap: US$47.4b

Operates as a cloud security company worldwide.

ZS

US$299.45

7D

-6.4%

1Y

48.6%

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$15.56

7D

7.2%

1Y

-18.3%

HubSpot

Market Cap: US$20.8b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

HUBS

US$396.36

7D

-0.5%

1Y

-41.5%

Sanmina

Market Cap: US$8.8b

Provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

SANM

US$160.37

7D

-5.8%

1Y

108.4%

Atlassian

Market Cap: US$39.9b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

TEAM

US$151.79

7D

-3.8%

1Y

-36.8%

Precigen

Market Cap: US$1.7b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

New

PGEN

US$4.85

7D

24.4%

1Y

491.4%

Kiniksa Pharmaceuticals International

Market Cap: US$3.1b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

KNSA

US$40.32

7D

5.1%

1Y

89.4%

Sunshine Biopharma

Market Cap: US$8.0m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

New

SBFM

US$1.63

7D

-5.2%

1Y

-30.5%

Zeta Global Holdings

Market Cap: US$4.4b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

ZETA

US$18.44

7D

-5.5%

1Y

4.9%

Reddit

Market Cap: US$36.6b

Operates a digital community in the United States and internationally.

RDDT

US$193.31

7D

-0.7%

1Y

54.9%

monday.com

Market Cap: US$8.3b

Develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally.

MNDY

US$160.54

7D

-15.3%

1Y

-38.9%

Semrush Holdings

Market Cap: US$1.1b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

New

SEMR

US$7.06

7D

-2.5%

1Y

-47.2%

SELLAS Life Sciences Group

Market Cap: US$203.7m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

New

SLS

US$1.43

7D

-10.1%

1Y

8.3%

BioRestorative Therapies

Market Cap: US$11.5m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

BRTX

US$1.33

7D

-2.9%

1Y

-8.3%

Krystal Biotech

Market Cap: US$6.0b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$206.16

7D

4.2%

1Y

20.7%

Interlink Electronics

Market Cap: US$62.1m

Provides sensors and printed electronics for use in human-machine interface (HMI) devices and internet-of-things solutions in the United States, Asia, the Middle East, Europe, and internationally.

New

LINK

US$4.20

7D

-17.4%

1Y

28.2%

Cheetah Mobile

Market Cap: US$202.5m

Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.

CMCM

US$6.68

7D

-8.0%

1Y

60.2%

Trade Desk

Market Cap: US$20.3b

Operates as a technology company in the United States and internationally.

TTD

US$41.93

7D

-2.5%

1Y

-64.5%

Savara

Market Cap: US$1.0b

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

New

SVRA

US$4.30

7D

8.9%

1Y

44.3%

MNTN

Market Cap: US$1.0b

Operates a technology platform that brings performance marketing to Connected TV.

MNTN

US$14.00

7D

-2.7%

1Y

n/a

Gyre Therapeutics

Market Cap: US$726.2m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

New

GYRE

US$7.99

7D

10.8%

1Y

-39.1%

Protalix BioTherapeutics

Market Cap: US$149.6m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

PLX

US$1.86

7D

-15.1%

1Y

32.9%

Protagonist Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$84.61

7D

6.4%

1Y

105.8%

Pure Storage

Market Cap: US$27.8b

Provides data storage and management technologies, products, and services in the United States and internationally.

PSTG

US$84.59

7D

-6.1%

1Y

75.5%

Annexon

Market Cap: US$392.2m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

New

ANNX

US$2.71

7D

-5.9%

1Y

-55.7%

Applied Optoelectronics

Market Cap: US$1.5b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$21.47

7D

-24.9%

1Y

-19.9%

Oncolytics Biotech

Market Cap: US$105.3m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

New

ONCY

US$1.04

7D

2.0%

1Y

6.1%

Canaan

Market Cap: US$592.8m

Engages in the research and development, design, and sale of integrated circuits (IC), and lease of final mining equipment by integrating IC products for bitcoin mining and related components in the People’s Republic of China.

CAN

US$0.89

7D

-25.0%

1Y

-45.9%

Page 1 of 3